Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Public ClinicalTrials.gov record NCT04806620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Unhide® Project Also Known as The Unhide® Solve Together Unified Platform
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years and older will provide self-reported health data, biometrics, and symptom diaries through the MyDataHelps™ app (branded as unhide® for this study). The goal is to create comprehensive longitudinal profiles to facilitate research into disease subtypes, causes, diagnostics, and potential treatments, as well as to identify potential participants for future optional studies. "Healthy" individuals without brain inflammation are also eligible to participate. The digital health research platform used in this study was originally developed and designed by Solve M.E and was called SolveTogether. The Brain Inflammation Collaborative (BIC) expanded upon Solve M.E.'s work to include related diagnoses, pediatric participants, enhance symptom tracking, and more. BIC and Solve M.E. combined Solve Together and unhide®, to create The unhide® Solve Together Unified Platform in 2025.
Study identification
- NCT ID
- NCT04806620
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 10,000 participants
Conditions and interventions
Conditions
- Post-Acute COVID-19 Syndrome
- ME/CFS
- Rheumatic Arthritis
- Juvenile Rheumatoid Arthritis (JRA)
- Psoriatic Arthritis (PsA)
- Ankylosing Spondylitis (AS)
- Autoimmune Encephalitis
- Celiac Disease
- Celiac Disease in Children
- Chronic Lyme Disease
- Post-treatment Lyme Disease Syndrome
- Crohn's Disease
- Dysautonomia
- Anorexia Nervosa
- Bulimia Nervosa
- ARFID
- Avoidant / Restrictive Food Intake Disorder
- Ehlers Danlos Syndrome
- Endometriosis
- Fibromyalgia (FM)
- Long COVID
- Lupus
- Migraines
- Mast Cell Activation Syndrome
- Multiple Sclerosis
- Myalgic Encephalomyelitis (ME)
- Myasthenia Gravis, Generalized
- Myasthenia Gravis in Children
- Narcolepsy
- Obsessive Compulsive Disorder (OCD)
- PANDAS
- Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
- POTS - Postural Orthostatic Tachycardia Syndrome
- General Anxiety Disorder, Social Anxiety Disorder
- PTSD - Post Traumatic Stress Disorder
- Psoriasis
- Traumatic Brain Injury
- Tourette's Syndrome
- Inflammatory Bowel Disease (IBD)
- Autoimmune Diseases
- Neurological Diseases or Conditions
- Psychiatric Disorder
- Sjogren's Syndrome
- Ulcerative Colitis and Crohn's Disease
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 4, 2023
- Primary completion
- Jun 29, 2030
- Completion
- Dec 30, 2030
- Last update posted
- Jan 21, 2026
2023 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Brain Inflammation Collaborative | Delafield | Wisconsin | 53018 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04806620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04806620 live on ClinicalTrials.gov.